ALDH2 and Myocardial fibrosis: Similarly, another potent ALDH2 activator, AD-9308, significantly improves diastolic and systolic myocardial function in diabetic models by enhancing mitochondrial respiration and reducing myocardial fibrosis, highlighting its potential to mitigate cardiac remodeling in DCM [65].